Literature DB >> 18541733

Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension.

Tang-Dong Liao1, Xiao-Ping Yang, Yun-He Liu, Edward G Shesely, Maria A Cavasin, William A Kuziel, Patrick J Pagano, Oscar A Carretero.   

Abstract

Angiotensin II (Ang II)-induced hypertension is associated with an inflammatory response that may contribute to the development of target organ damage. We tested the hypothesis that, in Ang II-induced hypertension, CC chemokine receptor 2 (CCR2) activation plays an important role in the development of renal fibrosis, damage, and dysfunction by causing oxidative stress, macrophage infiltration, and cell proliferation. To test this hypothesis, we used CCR2 knockout mice (CCR2-/-). The natural ligand of CCR2 is monocyte chemoattractant protein-1, a chemokine important for macrophage recruitment and activation. CCR2-/- and age-matched wild-type (CCR2+/+) C57BL/6J mice were infused continuously with either Ang II (5.2 ng/10 g per minute) or vehicle via osmotic minipumps for 2 or 4 weeks. Ang II infusion caused similar increases in systolic blood pressure and left ventricular hypertrophy in both strains of mice. However, in CCR2-/- mice with Ang II-induced hypertension, oxidative stress, macrophage infiltration, albuminuria, and renal damage were significantly decreased, and glomerular filtration rate was significantly higher than in CCR2+/+ mice. We concluded that, in Ang II-induced hypertension, CCR2 activation plays an important role in the development of hypertensive nephropathy via increased oxidative stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541733      PMCID: PMC2562771          DOI: 10.1161/HYPERTENSIONAHA.108.112706

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

1.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

Review 2.  Macrophages and progressive tubulointerstitial disease.

Authors:  Kevin Sean Eardley; Paul Cockwell
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

3.  A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin.

Authors:  J N Lorenz; E Gruenstein
Journal:  Am J Physiol       Date:  1999-01

4.  Angiotensin-converting enzyme inhibitors: a new mechanism of action.

Authors:  Hongmei Peng; Oscar A Carretero; Nikola Vuljaj; Tang-Dong Liao; Apurva Motivala; Edward L Peterson; Nour-Eddine Rhaleb
Journal:  Circulation       Date:  2005-10-10       Impact factor: 29.690

5.  Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.

Authors:  B I Freedman; H Yu; B J Spray; S S Rich; C B Rothschild; D W Bowden
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

6.  Is hypertension an inflammatory disease?

Authors:  Jian-Jun Li; Chun-Hong Fang; Rui-Tai Hui
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

7.  Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts.

Authors:  P J Pagano; S J Chanock; D A Siwik; W S Colucci; J K Clark
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

8.  Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.

Authors:  Mizuho Kobayashi; Hitoshi Sugiyama; Da-Hong Wang; Naomi Toda; Yohei Maeshima; Yasushi Yamasaki; Noriyoshi Masuoka; Masao Yamada; Shohei Kira; Hirofumi Makino
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.

Authors:  Rhian M Touyz; Chantel Mercure; Ying He; Danesh Javeshghani; Guoying Yao; Glaucia E Callera; Alvaro Yogi; Nadheige Lochard; Timothy L Reudelhuber
Journal:  Hypertension       Date:  2005-03-07       Impact factor: 10.190

Review 10.  Angiotensin II, nitric oxide, and end-organ damage in hypertension.

Authors:  A Bataineh; L Raij
Journal:  Kidney Int Suppl       Date:  1998-12       Impact factor: 10.545

View more
  75 in total

1.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice.

Authors:  Xiaomei Meng; Xiangguo Dai; Tang-Dong Liao; Martin D'Ambrosio; Fangfei Wang; James J Yang; Xiao-Ping Yang
Journal:  Life Sci       Date:  2010-11-11       Impact factor: 5.037

3.  Reactive oxygen species, NADPH oxidases, and hypertension.

Authors:  Srinivasa Raju Datla; Kathy K Griendling
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

4.  A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.

Authors:  Jian-dong Zhang; Mehul B Patel; Young-Soo Song; Robert Griffiths; James Burchette; Phillip Ruiz; Matthew A Sparks; Ming Yan; David N Howell; Jose A Gomez; Robert F Spurney; Thomas M Coffman; Steven D Crowley
Journal:  Circ Res       Date:  2012-04-24       Impact factor: 17.367

Review 5.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

Review 6.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

7.  Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.

Authors:  Qiongxin Wang; Miao Zhang; Ye Ding; Qilong Wang; Wencheng Zhang; Ping Song; Ming-Hui Zou
Journal:  Circ Res       Date:  2013-11-26       Impact factor: 17.367

Review 8.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

Review 9.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

10.  Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.

Authors:  Libor Kopkan; Zuzana Husková; Šárka Jíchová; Lenka Červenková; Luděk Červenka; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Clin Exp Hypertens       Date:  2015-07-07       Impact factor: 1.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.